At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 46 enrolled
Drug / intervention
NPWT and lyopreserved Stravix +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Randomized, Single-Center Study to Compare Clinical Outcomes Between Cryopreserved and Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds
University of Texas Southwestern Medical Center·interventional·Posted May 28, 2020·Updated Jul 24, 2023
In Brief
A Phase 4 clinical trial evaluating NPWT and lyopreserved Stravix and NPWT and cryopreserved Stravix for Diabetic Wound. Completed, enrolled 46 participants across 1 site.
Detailed Summary
This study is a prospective, 2-arm parallel assignment, randomized clinical trial to compare lyopreserved vs cryopreserved Stravix as an adjunct therapy to NPWT.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Wound
CountriesUnited States
CollaboratorsOsiris Therapeutics
Timeline
Phase 4CompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartJun 2021
Primary CompletionJul 2022
TodayJul 2026
First PostedMay 28, 2020
Enrollment StartJun 22, 2021
Primary CompletionJul 7, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 6.1 years ago
Interventions
NPWT and lyopreserved Stravixdevice
Subjects will be treated with NPWT and lyopreserved Stravix
NPWT and cryopreserved Stravixdevice
Subjects will be treated with NPWT and lyopreserved Stravix